|
Fatty acid |
ECL |
Relative abundance (%) |
1 |
n-tetradecanoic (n-14:0) |
14.00 |
|
1.0 |
2.0 |
4.7 |
2.0 |
6.2 |
2 |
4, 8,12-trimethyltridecanoic (r-16:0) |
14.51 |
|
4.6 |
6.5 |
11.3 |
1.5 |
7.0 |
3 |
13-methytetradecanoic (i-15:0) |
14.64 |
0.9 |
4.1 |
0.4 |
0.8 |
1.7 |
0.5 |
4 |
12-methyltetradecanoic (ai-15:0) |
14.71 |
|
0.4 |
0.6 |
0.6 |
1.5 |
0.6 |
5 |
n-pentadecanoic (n-15:0) |
15.00 |
0.9 |
0.6 |
0.9 |
1.7 |
1.3 |
5.8 |
6 |
14-methylpentadecanoic (i-16:0) |
15.66 |
|
|
|
0.9 |
0.9 |
1.0 |
7 |
9-hexadecenoic (16:1) |
15.76 |
3.3 |
1.7 |
2.1 |
5.8 |
1.7 |
1.6 |
8 |
n-hexadecanoic (n-16:0) |
16.00 |
11.3 |
15.1 |
10.2 |
13.4 |
12.1 |
12.4 |
9 |
15-methyl-9-hexadecenoic (i-17:1) |
16.32 |
0.6 |
|
|
|
1.4 |
|
10 |
10-methylhexadecanoic (r-17:0) |
16.40 |
0.7 |
|
|
|
5.1 |
|
11 |
8-heptadecenoic (17:1) |
16.49 |
|
|
0.9 |
|
|
|
12 |
15-methylhexadecanoic (i-17:0) |
16.63 |
1.0 |
0.5 |
0.5 |
0.2 |
1.2 |
|
13 |
14-methylhexadecanoic (ai-17:0) |
16.71 |
|
0.6 |
0.9 |
1.1 |
1.3 |
0.9 |
14 |
9-heptadecenoic (17:1) |
16.81 |
1.1 |
1.1 |
1.4 |
0.6 |
|
1.1 |
15 |
n-heptadecanoic (n-17:0) |
17.00 |
|
0.8 |
0.8 |
0.8 |
1.6 |
2.5 |
16 |
2-methoxyhexadecanoic (2-OMe-16:0) |
17.24 |
0.4 |
|
|
|
|
|
17 |
16-methylheptadecanoic (i-18:0) |
17.61 |
|
|
|
5.7 |
|
|
18 |
6, 9, 12, 15-octadecatetraenoic (18:4) |
17.43 |
|
|
1.9 |
|
|
|
19 |
9,12-octadecadienoic (18:2) |
17.60 |
2.2 |
0.8 |
1.2 |
1.6 |
1.1 |
1.1 |
20 |
5-octadecenoic (18:1) |
17.68 |
|
|
4.7 |
|
|
|
21 |
9-octadecenoic (18:1) |
17.71 |
4.9 |
4.2 |
2.9 |
4.9 |
3.0 |
3.7 |
22 |
3,7,11,15-tetrametilhexadecanoic (r-20:0) |
17.75 |
18.6 |
|
|
|
14.9 |
1.9 |
23 |
11-octadecenoic (18:1) |
17.79 |
|
1.8 |
|
|
3.4 |
0.5 |
24 |
n-octadecanoic (n-18:0) |
18.00 |
6 |
8.3 |
6 |
9.2 |
8 |
11 |
25 |
11-metiloctadecanoic (r-19:0) |
18.45 |
1.3 |
1 |
|
|
|
|
26 |
15-metiloctadecanoic (r-19:0) |
18.57 |
0.7 |
0.6 |
0.7 |
|
|
|
27 |
16-metiloctadecanoic (ai-19:0) |
18.70 |
|
0.5 |
0.3 |
|
|
|
28 |
17-metiloctadecanoic (i-19:0) |
18.63 |
|
|
0.3 |
|
0.9 |
|
29 |
11-nonadecenoic (19:1) |
18.81 |
|
0.4 |
|
0.5 |
|
|
30 |
n-nonadecanoic (n-19:0) |
19.00 |
|
0.7 |
0.6 |
0.7 |
|
7.0 |
31 |
5,8,11,14-icosatetraenoic (20:4) |
19.23 |
3.6 |
|
3 |
2.8 |
2.7 |
|
32 |
8,11,14,17-icosatetraenoic (20:4) |
19.26 |
|
|
1.5 |
|
2.8 |
|
33 |
8, 11, 14-icosatetraenoic (20:3) |
19.41 |
|
|
0.5 |
|
|
|
34 |
6,11-icosadienoic (20:2) |
19.58 |
1.8 |
|
1.1 |
|
|
|
35 |
18-metilnonadecanoic (i-20:0) |
19.63 |
|
|
|
1.1 |
|
|
36 |
11-icosenoic (20:1) |
19.67 |
1.3 |
|
|
|
|
|
37 |
13-icosenoic (20;1) |
19.74 |
0.6 |
0.5 |
0.7 |
0.5 |
|
|
38 |
n-icosanoic (20:0) |
20.00 |
0.6 |
3.7 |
1.4 |
1.7 |
|
1.8 |
39 |
13-heneicosenoic (21:1) |
20.84 |
0.8 |
|
|
|
|
|
40 |
n-heneicosanoic (n-21:0) |
21.00 |
|
|
|
0.8 |
|
0.6 |
41 |
4, 7, 10, 13, 16, 19-docosahexaenoic (22:6 n-3) |
21.10 |
|
|
4.1 |
|
|
|
42 |
10, 13, 16, 19-docosatetraenoic (22:4 n-3) |
21.22 |
|
|
0.5 |
|
|
|
43 |
7, 10, 13, 16-docosatetraenoic (22:4 n-6) |
21.13 |
0.9 |
|
0.4 |
|
|
|
44 |
n-docosanoic (n-22:0) |
22.00 |
|
1.2 |
1 |
1.4 |
|
3.1 |
45 |
16-tricosenoic (23:1) |
22.71 |
1.1 |
0.6 |
|
|
|
0.8 |
46 |
n-tricosanoic (23:0) |
23.00 |
|
0.3 |
0.4 |
0.5 |
0.4 |
0.6 |
47 |
16-tetracosenoic (24:1) |
23.90 |
|
|
|
1.6 |
|
|
48 |
17-tetracosenoic (24:1) |
23.77 |
|
1.5 |
2.4 |
|
|
|
49 |
n-tetracosanoic (n-24:0) |
24.00 |
|
0.8 |
2.8 |
1.1 |
1.1 |
3.1 |
50 |
5,9-pentacosadienoic (25:2) |
24.45 |
2.2 |
0.7 |
0.9 |
|
2.2 |
|
51 |
19-methyltetracosanoic (r-25:0) |
24.57 |
|
|
|
|
0.5 |
|
52 |
9-pentacosenoic (25:1) |
24.66 |
0.5 |
|
|
|
|
|
53 |
23-methyl-5,9-tetracosadienoic (i-25;2) |
24.08 |
|
|
|
|
0.5 |
|
54 |
18-pentacosenoic (25:1) |
24.87 |
0.1 |
2.8 |
|
|
|
|
55 |
n-pentacosanoic (n-25:0) |
25.00 |
|
|
|
0.4 |
0.3 |
|
56 |
2-hydroxitetracosanoic (2-OH-24:0) |
25.27 |
0.6 |
|
|
|
0.8 |
|
57 |
5,9-hexacosadienoic (26:2) |
25.50 |
25.6 |
11.8 |
14.8 |
1.2 |
6.2 |
2.3 |
58 |
9-hexacosenoic (26:1) |
25.63 |
0.5 |
1 |
1.8 |
1 |
|
|
59 |
17-hexacosenoic (26:1) |
25.73 |
|
0.9 |
1.5 |
2.5 |
0.6 |
0.6 |
60 |
23-methyl-5,9-pentacosadienoic (ai-26:2) |
25.22 |
|
|
|
|
0.5 |
|
61 |
19-hexacosenoic (26:1) |
25.77 |
0.4 |
1.8 |
1.5 |
0.4 |
|
|
62 |
n-hexacosanoic (26:0) |
26.00 |
0.5 |
|
1.6 |
0.8 |
0.4 |
1.2 |
63 |
2-hydroxipentacosanoic (2-OH-25:0) |
26.25 |
0.5 |
|
|
|
|
|
64 |
5,9-heptacosadienoic (27:2) |
26.50 |
0.5 |
1.2 |
2.1 |
1.1 |
0.7 |
1.6 |
65 |
6-Bromo-23-methyl-5,9-tetracosadienoic (6-Br-i-25:2) |
26.57 |
0.3 |
|
|
|
|
|
66 |
19-methylhexacosanoic (r-26:0) |
26.50 |
|
|
|
|
1.8 |
|
67 |
19-heptacosenoic (27:1) |
26.92 |
|
0.8 |
|
|
|
|
68 |
n-heptacosanoic (n-27:0) |
27.00 |
|
|
|
0.5 |
|
|
69 |
6-Bromo-5,9-pentacosadienoic (6-Br-25:2) |
26.96 |
0.3 |
|
|
|
0.3 |
|
70 |
26-methyl-5,9-heptacosadienoic (i-28:2) |
27.20 |
|
|
|
0.4 |
|
0.3 |
71 |
25-methyl-5,9-heptacosadienoic (ai-28:2) |
27.23 |
|
|
|
|
|
0.8 |
72 |
2-hydroxihexacosanoic (2-OH-26:2) |
27.30 |
0.3 |
|
|
|
|
|
73 |
5,9,21-octacosatrienoic (28:3) |
27.35 |
|
|
|
1 |
|
|
74 |
5,9-octacosadienoic (28:2) |
27.50 |
0.4 |
|
0.4 |
5.1 |
|
11.9 |
75 |
6-Bromo-24-methyl-5,9-pentacosadienoic (6-Br-i-26:2) |
27.60 |
0.4 |
|
|
|
|
|
76 |
6.Bromo.5,9.hexacosadienoic (6-Br-26:2) |
28.17 |
|
16.8 |
8 |
|
8 |
|
77 |
6-Bromo-5,9-heptacosadienoic (6-Br-27:2) |
29.04 |
|
2.2 |
1.4 |
|
1.4 |
|
78 |
5,9-nonacosadienoic (29:2) |
28.54 |
|
|
|
0.7 |
|
0.5 |
79 |
2-methoxyhexacosatetraenoic (2-OMe-26:4) |
28.61 |
|
|
|
|
|
1.1 |
80 |
5,9,23-triacontatrienoic (30:3) |
29.33 |
|
|
|
4.4 |
|
|
81 |
n-triacontanoic (n.30:0) |
30.00 |
|
|
|
1.4 |
|
|
82 |
dotriacontenoic (32:1) |
|
|
|
|
|
0.5 |
|
83 |
dotriacontanoic (32:0) |
|
|
|
|
0.6 |
|
|